What is the latest ALPA stock price?
The latest stored price for ALPA is Rs 59.35 as of 2026-09-18.
gimli
ALPA stock AI analysis
ALPA Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
ALPA LABORATORIES LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available ALPA price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹59.35
1W return
-5.22%
1M return
-5.13%
3M return
-12.54%
6M return
-1.03%
1Y return
-37.08%
Market cap
₹124.88 cr
PE
8.24
PB
0.67
ROE
+8.48%
ROCE
+9.42%
RSI
34.64
Turnover
₹0.10 cr
Why it can matter in screens
- Momentum: ALPA is below 50DMA, below 200DMA; RSI is 34.64.
- Returns: 1D -0.49%, 1W -5.22%, 1M -5.13%, 3M -12.54%, 1Y -37.08%.
- Trend levels: 52W high ₹78.89, 52W low ₹55.76, off high -24.77%.
- Liquidity: latest turnover is ₹0.10 cr; volume vs 20D is +1.28%.
- Valuation/profitability: PE 8.24, PB 0.67, ROE +8.48%, ROCE +9.42%.
- Growth: 3Y sales CAGR +4.62%, 3Y profit CAGR +6.06%.
Quick Answers
Is ALPA above its 50DMA and 200DMA?
ALPA is below 50DMA, below 200DMA. The latest 50DMA is 65.03 and the latest 200DMA is 68.26.
What are ALPA PE, ROE and ROCE?
ALPA has PE 8.24, ROE +8.48%, and ROCE +9.42% in Gimli's latest available snapshot.
How has ALPA performed recently?
ALPA has returned -5.13% over 1 month, -12.54% over 3 months, and -37.08% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 31.40 cr | 3.44 cr | 1.38 cr | 0.24 |
| 2025-12-31 | 29.05 cr | 2.42 cr | 1.90 cr | 0.90 |
| 2025-09-30 | 26.26 cr | 0.82 cr | 0.11 cr | 0.05 |
| 2025-06-30 | 19.11 cr | 12.37 cr | 11.77 cr | 5.59 |
| 2025-03-31 | 39.92 cr | 2.67 cr | -2.12 cr | -0.95 |
| 2024-12-31 | 26.15 cr | 9.54 cr | 8.90 cr | 4.23 |
| 2024-09-30 | 24.94 cr | 10.23 cr | n/a | 3.66 |
| 2024-06-30 | 21.44 cr | 5.69 cr | 5.10 cr | 2.42 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 105.81 cr | 19.05 cr | 15.01 cr | nan |
| 2025-03-31 | 112.45 cr | 28.10 cr | 19.50 cr | 9.34 |
| 2024-03-31 | 107.92 cr | 22.96 cr | 16.78 cr | 7.97 |
| 2023-03-31 | 92.41 cr | 17.30 cr | 12.58 cr | 5.88 |
| 2022-03-31 | 123.06 cr | 21.33 cr | 14.13 cr | 6.70 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 242.14 cr | 0.64 cr | 2.51 cr | 186.28 cr |
| 2025-03-31 | 222.63 cr | 2.22 cr | 0.03 cr | 171.43 cr |
| 2024-03-31 | 182.37 cr | 1.71 cr | 5.25 cr | 151.91 cr |
| 2023-03-31 | 167.27 cr | 8.81 cr | 2.30 cr | 134.58 cr |
| 2022-03-31 | 155.24 cr | 1.58 cr | 5.84 cr | 121.73 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 9.95 cr | 6.00 cr | n/a |
| 2025-03-31 | 7.06 cr | -4.32 cr | n/a |
| 2024-03-31 | 3.65 cr | -2.74 cr | n/a |
| 2023-03-31 | 8.90 cr | 7.78 cr | n/a |
| 2022-03-31 | 9.94 cr | 7.75 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +57.19% | +0.35% | +0.07% | +0.00% | +42.39% | +0.00% |
| 2026-03-31 | +57.19% | +0.38% | +0.00% | +0.00% | +42.43% | +0.00% |
| 2025-12-31 | +57.29% | +0.36% | +0.00% | +0.00% | +42.35% | +0.00% |
| 2025-09-30 | +57.29% | +0.35% | +0.00% | +0.00% | +42.35% | +0.00% |
| 2025-06-30 | +57.29% | +0.36% | +0.00% | +0.00% | +42.34% | +0.00% |
| 2025-03-31 | +57.29% | +0.40% | +0.00% | +0.00% | +42.31% | +0.00% |
| 2024-12-31 | +57.29% | +0.35% | +0.00% | +0.00% | +42.35% | +0.00% |
| 2024-09-30 | +57.29% | +0.74% | +0.00% | +0.00% | +41.96% | +0.00% |
| 2024-06-30 | +57.29% | +0.36% | +0.00% | +0.00% | +42.35% | +0.00% |
| 2024-03-31 | +57.29% | +0.50% | +0.00% | +0.00% | +42.20% | +0.00% |
| 2023-12-31 | +57.29% | +0.95% | +0.00% | +0.00% | +41.75% | n/a |
| 2023-09-30 | +57.29% | +0.11% | +0.00% | +0.00% | +42.60% | n/a |
| 2023-06-30 | +57.29% | +0.00% | +0.01% | +0.00% | +42.69% | +0.00% |
| 2023-03-31 | +57.29% | +0.00% | +0.01% | +0.00% | +42.69% | n/a |
| 2022-12-31 | +57.29% | +0.00% | +0.00% | +0.00% | +42.71% | n/a |
| 2022-09-30 | +57.29% | +0.14% | +0.00% | +0.00% | +42.56% | n/a |
| 2022-06-30 | +57.29% | +0.00% | +0.21% | n/a | n/a | n/a |
| 2022-03-31 | +57.29% | +0.00% | +0.56% | n/a | n/a | n/a |
| 2021-12-31 | +56.66% | +0.05% | +0.09% | n/a | n/a | +0.00% |
| 2021-09-30 | +56.66% | +0.00% | +0.00% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 440,829.82 cr | 36.388220 | +15.50% | +11.45% |
| DIVISLAB | DIVI S LABORATORIES LTD | 248,876.81 cr | 85.407280 | +18.37% | +53.39% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 163,807.57 cr | 75.106636 | +17.33% | +35.67% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,608.22 cr | 65.670049 | +21.03% | +13.94% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 116,723.14 cr | 26.011308 | +16.04% | +10.70% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 33.401961 | +10.25% | -11.64% |
| LAURUSLABS | LAURUS LABS LIMITED | 105,487.98 cr | 96.587446 | +21.77% | +111.64% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 102,122.47 cr | 70.799892 | +14.33% | -10.58% |
Try these prompts
- Analyze ALPA LABORATORIES with valuation, momentum and industry peers
- Compare ALPA with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ALPA with other Healthcare stocks
Data snapshot: 2026-09-18. Not investment advice.